320 related articles for article (PubMed ID: 25591906)
21. Prevalence of comorbid psychiatric illness and substance misuse in primary care in England and Wales.
Frisher M; Collins J; Millson D; Crome I; Croft P
J Epidemiol Community Health; 2004 Dec; 58(12):1036-41. PubMed ID: 15547069
[TBL] [Abstract][Full Text] [Related]
22. Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery.
Havassy BE; Alvidrez J; Owen KK
Am J Psychiatry; 2004 Jan; 161(1):139-45. PubMed ID: 14702262
[TBL] [Abstract][Full Text] [Related]
23. Comparison of health-related quality of life among men with different co-existing severe mental disorders in treatment for substance use.
Adan A; Marquez-Arrico JE; Gilchrist G
Health Qual Life Outcomes; 2017 Oct; 15(1):209. PubMed ID: 29061151
[TBL] [Abstract][Full Text] [Related]
24. Rural and urban differences in patients with a dual diagnosis.
Mueser KT; Essock SM; Drake RE; Wolfe RS; Frisman L
Schizophr Res; 2001 Mar; 48(1):93-107. PubMed ID: 11278157
[TBL] [Abstract][Full Text] [Related]
25. Comorbid substance and mental disorders among rural Americans: results from the National Comorbidity Survey.
Simmons LA; Havens JR
J Affect Disord; 2007 Apr; 99(1-3):265-71. PubMed ID: 16978706
[TBL] [Abstract][Full Text] [Related]
26. [Risk of homicide and major mental disorders: a critical review].
Richard-Devantoy S; Olie JP; Gourevitch R
Encephale; 2009 Dec; 35(6):521-30. PubMed ID: 20004282
[TBL] [Abstract][Full Text] [Related]
27. Social exclusion in clients with comorbid mental health and substance misuse problems.
Todd J; Green G; Harrison M; Ikuesan BA; Self C; Pevalin DJ; Baldacchino A
Soc Psychiatry Psychiatr Epidemiol; 2004 Jul; 39(7):581-7. PubMed ID: 15243697
[TBL] [Abstract][Full Text] [Related]
28. Do individuals with a severe mental illness experience greater alcohol and drug-related problems? A test of the supersensitivity hypothesis.
Gonzalez VM; Bradizza CM; Vincent PC; Stasiewicz PR; Paas ND
Addict Behav; 2007 Mar; 32(3):477-90. PubMed ID: 16828977
[TBL] [Abstract][Full Text] [Related]
29. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
Verdoux H; Mury M; Besançon G; Bourgeois M
Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
[TBL] [Abstract][Full Text] [Related]
30. Typology of individuals with substance dependence based on a Montreal longitudinal catchment area study.
Fleury MJ; Grenier G; Bamvita JM; Perreault M; Caron J
Adm Policy Ment Health; 2015 Jul; 42(4):405-19. PubMed ID: 25124748
[TBL] [Abstract][Full Text] [Related]
31. Crack Cocaine Use in Adolescents: Clinical Characteristics and Predictors of Early Initiation.
Pianca TG; Rohde LA; Rosa RL; Begnis AP; Ferronatto PB; Jensen MC; Pechansky F; Ceresér KM; Fairchild VP; Szobot CM
J Clin Psychiatry; 2016 Oct; 77(10):e1205-e1210. PubMed ID: 27574840
[TBL] [Abstract][Full Text] [Related]
32. [Cannabis and schizophrenia: demographic and clinical correlates].
Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
[TBL] [Abstract][Full Text] [Related]
33. Service use and barriers to mental health care among adults with major depression and comorbid substance dependence.
Chen LY; Crum RM; Martins SS; Kaufmann CN; Strain EC; Mojtabai R
Psychiatr Serv; 2013 Sep; 64(9):863-70. PubMed ID: 23728427
[TBL] [Abstract][Full Text] [Related]
34. Treatment prospects for persons with severe mental illness in an urban county jail.
Lamb HR; Weinberger LE; Marsh JS; Gross BH
Psychiatr Serv; 2007 Jun; 58(6):782-6. PubMed ID: 17535937
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder.
Miles H; Johnson S; Amponsah-Afuwape S; Finch E; Leese M; Thornicroft G
Psychiatr Serv; 2003 Apr; 54(4):554-61. PubMed ID: 12663845
[TBL] [Abstract][Full Text] [Related]
36. Comorbidity of Physical Disorders Among Patients With Severe Mental Illness With and Without Substance Use Disorders: A Systematic Review and Meta-Analysis.
Onyeka IN; Collier Høegh M; Nåheim Eien EM; Nwaru BI; Melle I
J Dual Diagn; 2019; 15(3):192-206. PubMed ID: 31164045
[No Abstract] [Full Text] [Related]
37. Long-term course of substance use disorders among patients with severe mental illness.
Bartels SJ; Drake RE; Wallach MA
Psychiatr Serv; 1995 Mar; 46(3):248-51. PubMed ID: 7796211
[TBL] [Abstract][Full Text] [Related]
38. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Hasin DS; Stinson FS; Ogburn E; Grant BF
Arch Gen Psychiatry; 2007 Jul; 64(7):830-42. PubMed ID: 17606817
[TBL] [Abstract][Full Text] [Related]
39. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample.
Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
Aust N Z J Psychiatry; 2014 Nov; 48(11):1036-47. PubMed ID: 24819935
[TBL] [Abstract][Full Text] [Related]
40. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
